HIGHLIGHTS
- who: Rita Consolini from the Case Western Reserve University, United States have published the article: Refractory immune thrombocytopenia: lessons from immune dysregulation disorders, in the Journal: (JOURNAL)
SUMMARY
Despite the wide number of therapeutic options, a small percentage of the patients with chronic ITP show refractoriness to treatment, which is defined by the lack of hematological response (defined by a platelet count and amp;lt; 30,000/µl or relapses with bleeding) to immunosuppressive agents and TPO-RAS. Among IEI, there is increasing interest on a subcategory of diseases called "immune dysregulation disorders . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.